Fri, November 17, 2017
Thu, November 16, 2017
Wed, November 15, 2017
Tue, November 14, 2017
Mon, November 13, 2017
Fri, November 10, 2017
Thu, November 9, 2017
Wed, November 8, 2017
Tue, November 7, 2017
Mon, November 6, 2017
Fri, November 3, 2017

Anupam Rama Upgraded (ALNY) to Buy on, Nov 9th, 2017


//stocks-investing.news-articles.net/content/201 .. m-rama-upgraded-alny-to-buy-on-nov-9th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Anupam Rama of JP Morgan, Upgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Buy on, Nov 9th, 2017.

Anupam has made no other calls on ALNY in the last 4 months.



There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $112 on, Thursday, September 21st, 2017


These are the ratings of the 8 analyists that currently disagree with Anupam


  • Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $158 on, Wednesday, November 8th, 2017
  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $220 on, Wednesday, November 8th, 2017
  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $151 on, Friday, November 3rd, 2017
  • Rahul Jasuja of "FBR Capital" Maintained at Strong Buy with Increased Target to $240 on, Thursday, November 2nd, 2017
  • Terence Flynn of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Monday, October 2nd, 2017
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $134 on, Friday, September 22nd, 2017
  • Alan Carr of "Needham" Maintained at Strong Buy with Increased Target to $125 on, Thursday, September 21st, 2017
  • Christopher Marai of "Nomura" Initiated at Sell and Held Target at $56 on, Friday, September 15th, 2017

Publication Contributing Sources